bioMérieux Customer: Laboratory Report
System #: Printed by: LabSuper
Patient Name: Patient ID:
Isolate: ATCC25913/23-2 (Qualified) Bench: ATCC
Card Type: AST-P628 Bar Code: 5382385203447836 Testing Instrument: 000019E1EA62 (17975)
Setup Technologist: Laboratory Supervisor(LabSuper)
Organism Quantity: Selected Organism: Staphylococcus aureus
BP Infection Site:
Comments:
Identification Information
Organism Origin Technologist
Staphylococcus aureus
Selected Organism
Entered: Aug 28, 2023 09:46 IST By: LabSuper
Analysis Messages:
The following antibiotic(s) are not claimed:
Gentamicin High Level (synergy),
Susceptibility Card: AST-P628 Lot Number: 5382385203 Expires: Jun 7, 2024 12:00 IST
Information Status: Final Analysis Time: 12.33 hours Completed: Aug 23, 2023 01:45 IST
Antimicrobial MIC Interpretation Antimicrobial MIC Interpretation
Cefoxitin Screen NEG - Linezolid 4 S
Benzylpenicillin 0.12 S Daptomycin 1 S
Oxacillin 0.5 S Teicoplanin <= 0.5 S
Gentamicin High Level Vancomycin 1 S
(synergy)
Gentamicin <= 0.5 S Tetracycline <= 1 S
Ciprofloxacin <= 0.5 S Tigecycline <= 0.12 S
Levofloxacin 0.25 S Nitrofurantoin 32 S
Inducible Clindamycin NEG - Rifampicin <= 0.03 S
Resistance
Erythromycin <= 0.25 S Trimethoprim/ <= 10 S
Sulfamethoxazole
Clindamycin 0.25 S
AES Findings: Last Modified: Jun 5, 2023 17:21 IST Parameter Set: Global CLSI-based+Natural
Resistance
Confidence Level: Consistent
Phenotypes flagged for MACROLIDES/LINCOSAMIDES/ RESISTANT TO STREPTOGRAMINS (SGA-SGB)
review: STREPTOGRAMINS
Installed VITEK 2 Systems Version: 9.02
MIC Interpretation Guideline: Global CLSI-based 2023 Therapeutic Interpretation Guideline: Copy of NATURAL
RESISTANCE
AES Parameter Set Name: Global CLSI-based+Natural Resistance AES Parameter Last Modified: Jun 5, 2023 17:21 IST
Page 1 of 2
bioMérieux Customer: Laboratory Report
System #: Printed by: LabSuper
Patient Name: Patient ID:
Isolate: ATCC25913/23-2 (Qualified) Bench: ATCC
Card Type: AST-P628 Bar Code: 5382385203447836 Testing Instrument: 000019E1EA62 (17975)
Setup Technologist: Laboratory Supervisor(LabSuper)
Organism Quantity: Selected Organism: Staphylococcus aureus
BP Infection Site:
Action Name (User ID) Date/Time Comment
Installed VITEK 2 Systems Version: 9.02
MIC Interpretation Guideline: Global CLSI-based 2023 Therapeutic Interpretation Guideline: Copy of NATURAL
RESISTANCE
AES Parameter Set Name: Global CLSI-based+Natural Resistance AES Parameter Last Modified: Jun 5, 2023 17:21 IST
Page 2 of 2
bioMérieux Customer: Laboratory Report
System #: Printed by: LabSuper
Patient Name: Patient ID:
Isolate: ATCC25922/23-2 (Qualified) Bench: ATCC
Card Type: AST-N405 Bar Code: 1552428504740841 Testing Instrument: 000019E1EA62 (17975)
Setup Technologist: Laboratory Supervisor(LabSuper)
Organism Quantity: Selected Organism: Escherichia coli
BP Infection Site:
Susceptible of Colistin results should be confirmed with alternate micro broth dilution method as per CLSI
2017.
Colistin and Polymyxin B breakpoints for Enterobacteriaceae, Acinetobacter and Pseudomonas as per CLSI
Comments: 2020.(<=2 Intermediate, >=4 Resistant).
Identification Information
Organism Origin Technologist
Escherichia coli
Selected Organism
Entered: Aug 28, 2023 10:03 IST By: LabSuper
Analysis Messages:
Susceptibility Card: AST-N405 Lot Number: 1552428504 Expires: Jul 20, 2024 12:00 IST
Information Status: Final Analysis Time: 7.70 hours Completed: Aug 22, 2023 21:08 IST
Antimicrobial MIC Interpretation Antimicrobial MIC Interpretation
Amoxicillin/Clavulanic Acid <= 2 S Meropenem <= 0.25 S
Piperacillin/Tazobactam <= 4 S Amikacin 2 S
Cefuroxime <= 1 S Gentamicin <= 1 S
Cefuroxime Axetil <= 1 S Ciprofloxacin <= 0.06 S
Ceftriaxone <= 0.25 S Tigecycline <= 0.5 S
Cefoperazone/Sulbactam <= 8 S Fosfomycin <= 16 S
Cefepime <= 0.12 S Colistin <= 0.5 I
Ertapenem <= 0.12 S Trimethoprim/ <= 20 S
Sulfamethoxazole
Imipenem <= 0.25 S
AES Findings: Last Modified: Jun 5, 2023 17:21 IST Parameter Set: Global CLSI-based+Natural
Resistance
Confidence Level: Consistent
Installed VITEK 2 Systems Version: 9.02
MIC Interpretation Guideline: Global CLSI-based 2023 Therapeutic Interpretation Guideline: Copy of NATURAL
RESISTANCE
AES Parameter Set Name: Global CLSI-based+Natural Resistance AES Parameter Last Modified: Jun 5, 2023 17:21 IST
Page 1 of 2
bioMérieux Customer: Laboratory Report
System #: Printed by: LabSuper
Patient Name: Patient ID:
Isolate: ATCC25922/23-2 (Qualified) Bench: ATCC
Card Type: AST-N405 Bar Code: 1552428504740841 Testing Instrument: 000019E1EA62 (17975)
Setup Technologist: Laboratory Supervisor(LabSuper)
Organism Quantity: Selected Organism: Escherichia coli
BP Infection Site:
Action Name (User ID) Date/Time Comment
Installed VITEK 2 Systems Version: 9.02
MIC Interpretation Guideline: Global CLSI-based 2023 Therapeutic Interpretation Guideline: Copy of NATURAL
RESISTANCE
AES Parameter Set Name: Global CLSI-based+Natural Resistance AES Parameter Last Modified: Jun 5, 2023 17:21 IST
Page 2 of 2
bioMérieux Customer: Laboratory Report
System #: Printed by: LabSuper
Patient Name: Patient ID:
Isolate: ATCC27853/23-2 (Qualified) Bench: ATCC
Card Type: AST-N406 Bar Code: 1562435404022894 Testing Instrument: 000019E1EA62 (17975)
Setup Technologist: Laboratory Supervisor(LabSuper)
Organism Quantity: Selected Organism: Pseudomonas aeruginosa
BP Infection Site:
Susceptible of Colistin results should be confirmed with alternate micro broth dilution method as per CLSI
2017.
Colistin and Polymyxin B breakpoints for Enterobacteriaceae, Acinetobacter and Pseudomonas as per CLSI
Comments: 2020.(<=2 Intermediate, >=4 Resistant).
Identification Information
Organism Origin Technologist
Pseudomonas aeruginosa
Selected Organism
Entered: Aug 28, 2023 10:03 IST By: LabSuper
Analysis Messages:
Susceptibility Card: AST-N406 Lot Number: 1562435404 Expires: Jul 27, 2024 12:00 IST
Information Status: Final Analysis Time: 13.32 hours Completed: Aug 23, 2023 02:45 IST
Antimicrobial MIC Interpretation Antimicrobial MIC Interpretation
Piperacillin/Tazobactam <= 4 S Gentamicin
Ceftazidime 2 S Ciprofloxacin 0.5 S
Cefoperazone/Sulbactam <= 8 S Levofloxacin 1 S
Cefepime 2 S Minocycline
Aztreonam 4 S Tigecycline >= 8 R
Imipenem 2 S Fosfomycin
Meropenem <= 0.25 S Colistin 1 I
Amikacin 2 S Trimethoprim/
Sulfamethoxazole
AES Findings: Last Modified: Jun 5, 2023 17:21 IST Parameter Set: Global CLSI-based+Natural
Resistance
Confidence Level: Consistent
Installed VITEK 2 Systems Version: 9.02
MIC Interpretation Guideline: Global CLSI-based 2023 Therapeutic Interpretation Guideline: Copy of NATURAL
RESISTANCE
AES Parameter Set Name: Global CLSI-based+Natural Resistance AES Parameter Last Modified: Jun 5, 2023 17:21 IST
Page 1 of 2
bioMérieux Customer: Laboratory Report
System #: Printed by: LabSuper
Patient Name: Patient ID:
Isolate: ATCC27853/23-2 (Qualified) Bench: ATCC
Card Type: AST-N406 Bar Code: 1562435404022894 Testing Instrument: 000019E1EA62 (17975)
Setup Technologist: Laboratory Supervisor(LabSuper)
Organism Quantity: Selected Organism: Pseudomonas aeruginosa
BP Infection Site:
Action Name (User ID) Date/Time Comment
Installed VITEK 2 Systems Version: 9.02
MIC Interpretation Guideline: Global CLSI-based 2023 Therapeutic Interpretation Guideline: Copy of NATURAL
RESISTANCE
AES Parameter Set Name: Global CLSI-based+Natural Resistance AES Parameter Last Modified: Jun 5, 2023 17:21 IST
Page 2 of 2
